Stock listing
VX1 Stock Price, News, Filings & Events — Vertex Pharmaceuticals Incorporated
Selected listing: VX1 · GETTEX · EUR · DE
This page tracks Vertex Pharmaceuticals Incorporated's VX1:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VX1:GETTEX. VX1:GETTEX is the stock-level entry point for investors researching Vertex Pharmaceuticals Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- VX1:GETTEX
- Asset type
- Stock
- Market cap
- $137.30B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Vertex Pharmaceuticals Incorporated VX1:GETTEX stock context
This page tracks Vertex Pharmaceuticals Incorporated's VX1:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VX1:GETTEX. VX1:GETTEX is the stock-level entry point for investors researching Vertex Pharmaceuticals Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Vertex Pharmaceuticals Incorporated
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
September 1, 2026
Vertex to Announce Second Quarter 2026 Financial Results on Monday, August 3, 2026
July 14, 2026
Cystic Fibrosis Market, Global & Regional Now Available; Profiles Vertex Pharmaceuticals, AbbVie, and Other Frontrunner Competitors in Or...
July 9, 2026
Vertex to Announce Second Quarter 2026 Financial Results on August 3rd
July 7, 2026
Vertex to Acquire Crinetics Pharmaceuticals
July 6, 2026
Vertex Pharmaceuticals Incorporated earnings calls
Vertex Pharmaceuticals Incorporated (VRTX) Q2 2026 Earnings Call
August 3, 2026 · Replay with transcript and chapters
Vertex Pharmaceuticals Incorporated (VRTX) Q1 2026 Earnings Call
May 4, 2026 · Replay with transcript and chapters
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2025 Earnings Call
February 12, 2026 · Replay with transcript and chapters
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2025 Earnings Call
November 3, 2025 · Replay with transcript and chapters
Vertex Pharmaceuticals Incorporated (VRTX) Q2 2025 Earnings Call
August 4, 2025 · Replay with transcript and chapters
Vertex Pharmaceuticals Incorporated (VRTX) Q1 2025 Earnings Call
May 5, 2025 · Replay with transcript and chapters
Research Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated investor report
Review AI stock analysis and investor report context for VX1:GETTEX.
Vertex Pharmaceuticals Incorporated company profile
View the public company page for Vertex Pharmaceuticals Incorporated on 6ix.
Vertex Pharmaceuticals Incorporated news
Read company news and market updates connected to Vertex Pharmaceuticals Incorporated.
Vertex Pharmaceuticals Incorporated investor events
Find investor webinars, events, and replay context for Vertex Pharmaceuticals Incorporated.
Alternate listings
VRTX:NASDAQ
US · USD
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
VX1:XETR
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
VRTX:BCBA
AR · ARS
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
VX1:TRADEGATE
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
882807:LSX
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
VRTX:BMV
MX · MXN
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
VRTX34:BMFBOVESPA
BR · BRL
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
882807:LS
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
0QZU:LSE
GB · USD
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
VX1:FWB
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
4VRTX:EUROTLX
IT · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.
VRTXD:BCBA
AR · USD
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VX1:GETTEX.